West Pharmaceutical Services, Inc. (NYSE:WST – Get Free Report) hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $265.00 and last traded at $271.47, with a volume of 372711 shares changing hands. The stock had previously closed at $323.77.
West Pharmaceutical Services Price Performance
The company has a market cap of $19.96 billion, a price-to-earnings ratio of 35.81, a PEG ratio of 5.61 and a beta of 1.00. The company has a quick ratio of 1.95, a current ratio of 2.61 and a debt-to-equity ratio of 0.03. The company’s fifty day moving average price is $327.04 and its two-hundred day moving average price is $356.77.
West Pharmaceutical Services (NYSE:WST – Get Free Report) last released its quarterly earnings results on Thursday, April 25th. The medical instruments supplier reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.29 by $0.27. The company had revenue of $695.40 million during the quarter, compared to analysts’ expectations of $670.62 million. West Pharmaceutical Services had a net margin of 19.42% and a return on equity of 20.57%. The business’s quarterly revenue was down 3.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.98 earnings per share. On average, equities research analysts forecast that West Pharmaceutical Services, Inc. will post 7.76 EPS for the current fiscal year.
Insider Activity
Institutional Trading of West Pharmaceutical Services
A number of institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. lifted its position in shares of West Pharmaceutical Services by 1.2% in the fourth quarter. Vanguard Group Inc. now owns 9,002,632 shares of the medical instruments supplier’s stock worth $3,170,007,000 after purchasing an additional 104,740 shares in the last quarter. Franklin Resources Inc. raised its position in West Pharmaceutical Services by 1.3% during the fourth quarter. Franklin Resources Inc. now owns 2,105,589 shares of the medical instruments supplier’s stock worth $741,420,000 after acquiring an additional 28,010 shares in the last quarter. Artisan Partners Limited Partnership raised its position in West Pharmaceutical Services by 23.2% during the fourth quarter. Artisan Partners Limited Partnership now owns 1,961,063 shares of the medical instruments supplier’s stock worth $690,530,000 after acquiring an additional 369,792 shares in the last quarter. Brown Advisory Inc. raised its position in West Pharmaceutical Services by 8.4% during the fourth quarter. Brown Advisory Inc. now owns 1,414,431 shares of the medical instruments supplier’s stock worth $498,049,000 after acquiring an additional 109,369 shares in the last quarter. Finally, Norges Bank bought a new stake in West Pharmaceutical Services during the fourth quarter worth $300,250,000. Institutional investors own 93.90% of the company’s stock.
About West Pharmaceutical Services
West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.
Further Reading
- Five stocks we like better than West Pharmaceutical Services
- How to buy stock: A step-by-step guide for beginners
- Conviction Firms For Chipotle Stock’s 25% Share Price Increase
- ESG Stocks, What Investors Should Know
- Beauty Retailer Stock Brings Early Christmas for Value Investors
- Airline Stocks – Top Airline Stocks to Buy Now
- Ford Stock EPS Disappoints, Shares Plummet After-Hours
Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.